Anti-Cancer Drugs

An International Journal on Anti-Cancer Agents

An International Journal on Anti-Cancer Agents

ISBN/ISSN

0959-4973

Publication Frequency

Published 10 times per year

Term*

Price Type

Country

*Avoid future price increases! lock in your rate by opting-in to a 3-year term.

Institutional subscriptions are Print only and do not include online access.

$899.00

*Final price may vary based on conversion rate.

Quantity

System.String
""

Item already added to cart.

Not Purchasable: Not done configuring

Description

Anti-Cancer Drugs provides current information on the clinical and experimental effects of toxic and non-toxic cancer agents and is specifically directed towards breakthroughs in cancer treatment. Among the topics included are cytotoxic chemotherapy, hormonal or biological response modifiers such as interleukins, immunotherapy, drug design, adverse effects of drugs and drug resistance. Within the journal, strong emphasis is placed on papers reporting treatments to alleviate the side-effects of chemotherapy.

An individual subscription includes 10 print issues and full-text online access to all current and back issues.

Visit the journal online at anti-cancerdrugs.com
Specs

ISBN/ISSN

0959-4973

Product Format

PB-Paperback

Publication Frequency

Published 10 times per year
About The Editor(s)

Mels Sluyser PhD
The Netherlands Cancer Institute, Amsterdam, The Netherlands
Features

--Original clinical reports
--Preclinical reports
--Review articles
--Case reports
--Commentary
--Meeting reports
--Fast publication time
--Provides new developments and breakthrough research

--2012 Impact Factor: 2.232*
--2012 Ranking: 115 of 196 Oncology, 127 of 260 Pharmacology & Pharmacy*
--Website: www.anti-cancerdrugs.com

*2012 Journal Citation Reports® (Thomson Reuters, 2013)
Review

Login to Write a Review